Amedeo Smart

Free Medical Literature Service



Bacterial Infections and Mycoses

  Free Subscription

Articles published in
Nat Med
    April 2024

  1. Systematic testing in cholera surveillance enhances vaccine impact and cost-effectiveness.
    Nat Med. 2024 Apr 3. doi: 10.1038/s41591-024-02907.
    >> Share

    March 2024
  2. NUERMBERGER EL, Chaisson RE
    Restocking the tuberculosis drug arsenal.
    Nat Med. 2024 Mar 8. doi: 10.1038/s41591-024-02840.
    >> Share

  3. XU H, Zou K, Dent J, Wiens KE, et al
    Enhanced cholera surveillance to improve vaccination campaign efficiency.
    Nat Med. 2024 Mar 5. doi: 10.1038/s41591-024-02852.
    >> Share

  4. HEGDE ST, Khan AI, Perez-Saez J, Khan II, et al
    Clinical surveillance systems obscure the true cholera infection burden in an endemic region.
    Nat Med. 2024;30:888-895.
    >> Share

  5. KHAN S, Guo X, Awan UA
    Pakistan is failing in maternal and neonatal tetanus elimination.
    Nat Med. 2024;30:615.
    >> Share

    February 2024
  6. O'LEARY K
    Digital intervention improves tuberculosis treatment outcomes.
    Nat Med. 2024 Feb 19. doi: 10.1038/d41591-024-00009.
    >> Share

  7. DIACON AH, Barry CE 3rd, Carlton A, Chen RY, et al
    A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
    Nat Med. 2024 Feb 16. doi: 10.1038/s41591-024-02829.
    >> Share

    January 2024
  8. NAKAGAAYI D, Pulle J, Otim I, Akiya OC, et al
    A decentralized delivery program for rheumatic heart disease treatment and prevention in Uganda.
    Nat Med. 2024;30:12-13.
    >> Share

    December 2023
  9. ACKERMAN L, Acloque G, Bacchelli S, Schwartz H, et al
    IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
    Nat Med. 2023;29:3127-3136.
    >> Share

    October 2023
  10. GRILLO S, Pujol M, Miro JM, Lopez-Contreras J, et al
    Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.
    Nat Med. 2023 Oct 2. doi: 10.1038/s41591-023-02569.
    >> Share

  11. Genomic epidemiology of Clostridioides difficile in individuals admitted to an intensive care unit.
    Nat Med. 2023;29:2418-2419.
    >> Share

  12. MILES-JAY A, Snitkin ES, Lin MY, Shimasaki T, et al
    Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit.
    Nat Med. 2023;29:2526-2534.
    >> Share

  13. TANUI CK, Tessema SK, Tegegne MA, Tebeje YK, et al
    Unlocking the power of molecular and genomics tools to enhance cholera surveillance in Africa.
    Nat Med. 2023;29:2387-2388.
    >> Share

    August 2023
    GSK's gonorrhea vaccine receives fast-track designation to expedite clinical trials.
    Nat Med. 2023 Aug 7. doi: 10.1038/d41591-023-00069.
    >> Share

    March 2023
  15. ESMAIL A, Randall P, Oelofse S, Tomasicchio M, et al
    Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial.
    Nat Med. 2023 Mar 9. doi: 10.1038/s41591-023-02247.
    >> Share

    January 2023
  16. MCKENNA L, Frick M, Angami K, Dubula V, et al
    The 1/4/6x24 campaign to cure tuberculosis quickly.
    Nat Med. 2023 Jan 10. doi: 10.1038/s41591-022-02136.
    >> Share

  17. MUSVOSVI M, Huang H, Wang C, Xia Q, et al
    T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
    Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02110.
    >> Share

  18. OGONGO P, Ernst JD
    Finding antigens for TB vaccines: the good, the bad and the useless.
    Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02123.
    >> Share

    November 2022
    A new class of antibiotics delivers promising trial results against tuberculosis.
    Nat Med. 2022 Nov 30. doi: 10.1038/d41591-022-00114.
    >> Share

    September 2022
  20. IANIRO G, Puncochar M, Karcher N, Porcari S, et al
    Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Nat Med. 2022;28:1913-1923.
    >> Share

  21. SCHMIDT TSB, Li SS, Maistrenko OM, Akanni W, et al
    Drivers and determinants of strain dynamics following fecal microbiota transplantation.
    Nat Med. 2022;28:1902-1912.
    >> Share

  22. ISLAM MT, Ross AG, Sleigh AC, Chowdhury F, et al
    A blueprint for eliminating cholera by 2030.
    Nat Med. 2022;28:1747-1749.
    >> Share

    January 2022
  23. SINHA S, Rosin NL, Arora R, Labit E, et al
    Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
    Nat Med. 2022;28:201-211.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016